Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
ICICI Pru Nifty Healthcare ETF
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.18.506715874627.0932
Domestic EquitiesMAX Healthcare Institute Ltd9.313110942213.6340
Domestic EquitiesCipla Ltd.8.79408281312.8741
Domestic EquitiesDivi's Laboratories Ltd.8.42391869812.3323
Domestic EquitiesDr. Reddy's Laboratories Ltd.7.77908965011.3882
Domestic EquitiesApollo Hospitals Enterprise Ltd.7.61861487511.1533
Domestic EquitiesLupin Ltd.4.6908355986.8672
Domestic EquitiesFortis Healthcare Ltd.4.4936767206.5784
Domestic EquitiesTorrent Pharmaceuticals Ltd.3.9358153985.7618
Domestic EquitiesLaurus Labs Ltd.3.4412576185.0378
Domestic EquitiesGlenmark Pharmaceuticals Ltd.3.2318221704.7313
Domestic EquitiesAurobindo Pharma Ltd.3.2057411754.6931
Domestic EquitiesMankind Pharma Ltd2.9166166324.2698
Domestic EquitiesAlkem Laboratories Ltd.2.722179213.9851
Domestic EquitiesZydus Lifesciences Ltd.2.4354367643.5654
Domestic EquitiesBiocon Ltd.2.3641884243.4609
Domestic EquitiesIPCA Laboratories Ltd.2.0599204603.0156
Domestic EquitiesAbbott India Ltd.1.80497682.6423
Domestic EquitiesSyngene International Ltd.1.3609279041.9923
Domestic EquitiesGranules India Ltd.0.6926213491.0139
Total 99.7908 146.0900
Cash & Cash Equivalents and Net AssetsNet Current Assets0.2056 0.3009
Cash & Cash Equivalents and Net AssetsTREPS0.0037 0.0054
Total 0.2092 0.3063
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.